Phenominer Database Results (10 results)

 
 
How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Time Value Record ID Study ID
E3/Ztm body weight gain spinal cord homogenate (10 mg) Bergsteinsdottir K, et al., J Immunol 2000 Feb 1;164(3):1564-8 body mass female 56.0 days-103.0 days 12 80.0 g 0.87 3.0 body weighing method 0.0 69956 1258
DA/Ztm body weight gain spinal cord homogenate (10 mg) Bergsteinsdottir K, et al., J Immunol 2000 Feb 1;164(3):1564-8 body mass male 56.0 days-103.0 days 9 32.0 g 8.33 25.0 body weighing method 0.0 69948 1258
DA/Ztm percentage of study population developing relapsing-remitting experimental autoimmune encephalomyelitis during a period of time spinal cord homogenate (10 mg) Bergsteinsdottir K, et al., J Immunol 2000 Feb 1;164(3):1564-8 central nervous system integrity trait male 56.0 days-103.0 days 9 56.0 % in vivo visual assessment 0.0 69951 1258
E3/Ztm body weight gain spinal cord homogenate (10 mg) Bergsteinsdottir K, et al., J Immunol 2000 Feb 1;164(3):1564-8 body mass male 56.0 days-103.0 days 3 39.0 g 5.2 9.0 body weighing method 0.0 69957 1258
DA/Ztm post-insult time to onset of experimental autoimmune encephalomyelitis spinal cord homogenate (10 mg) Bergsteinsdottir K, et al., J Immunol 2000 Feb 1;164(3):1564-8 central nervous system integrity trait male 56.0 days-103.0 days 9 13.0 d 2.0 6.0 in vivo visual assessment 0.0 69952 1258
E3/Ztm percentage of study population developing experimental autoimmune encephalomyelitis during a period of time spinal cord homogenate (10 mg) Bergsteinsdottir K, et al., J Immunol 2000 Feb 1;164(3):1564-8 central nervous system integrity trait male 56.0 days-103.0 days 3 0.0 % in vivo visual assessment 0.0 69954 1258
DA/Ztm percentage of study population developing acute experimental autoimmune encephalomyelitis during a period of time spinal cord homogenate (10 mg) Bergsteinsdottir K, et al., J Immunol 2000 Feb 1;164(3):1564-8 central nervous system integrity trait male 56.0 days-103.0 days 9 22.0 % in vivo visual assessment 0.0 69950 1258
DA/Ztm experimental autoimmune encephalomyelitis duration spinal cord homogenate (10 mg) Bergsteinsdottir K, et al., J Immunol 2000 Feb 1;164(3):1564-8 central nervous system integrity trait male 56.0 days-103.0 days 9 9.0 d 2.67 8.0 in vivo visual assessment 0.0 69953 1258
E3/Ztm percentage of study population developing experimental autoimmune encephalomyelitis during a period of time spinal cord homogenate (10 mg) Bergsteinsdottir K, et al., J Immunol 2000 Feb 1;164(3):1564-8 central nervous system integrity trait female 56.0 days-103.0 days 12 0.0 % in vivo visual assessment 0.0 69955 1258
DA/Ztm percentage of study population developing experimental autoimmune encephalomyelitis during a period of time spinal cord homogenate (10 mg) Bergsteinsdottir K, et al., J Immunol 2000 Feb 1;164(3):1564-8 central nervous system integrity trait male 56.0 days-103.0 days 9 78.0 % in vivo visual assessment 0.0 69949 1258